跳至主要内容
临床试验/ISRCTN58369615
ISRCTN58369615已完成不适用

Biological factors of insulin resistance and cardiovascular risk factors in women with polycystic ovarian syndrome: modification with diet, metformin, pioglitazone and orlistat

Hull and East Yorkshire Hospitals NHS Trust (UK)0 个研究点目标入组 40 人开始时间: 2007年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • The diagnosis of PCOS will be based on evidence of hyperandrogenemia (Free androgen index > 8, with a history of oligomenorrhea and hirsutism or acne. Non classical 21-hydroxylase deficiency, hyperprolactinemia, and androgen secreting tumors will be excluded by appropriate tests before the diagnosis of PCOS will be made. Transvaginal ultrasound will also be performed to confirm the diagnosis of PCOS

排除标准

  • 1. No subjects will be taking any medication currently or for the preceding six months
  • 2. No concurrent illness
  • 3. Patients not wishing to allow disclosure to their GPs

研究者

发起方
Hull and East Yorkshire Hospitals NHS Trust (UK)

相似试验

Biological variation of insulin resistance on... | 临床试验